Balázs Győrffy

Semmelweis University — Hungary

Biochemistry, Genetics and Molecular Biology · Life Sciences

86h-index42.1kcitations1.3kworks4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(149), Epigenetics and DNA Methylation(138), Cancer Genomics and Diagnostics(124), Cancer Immunotherapy and Biomarkers(94), Bioinformatics and Genomic Networks(77)

Publications1.3k total

Condensate-Driven Transcriptional Reprogramming Defines Core Vulnerabilities in Esophageal and Gastric Cancers
2026Open Access
Abstract PS3-04-24: Common and rare germline variants together with somatic mutations alter the integrity of cancer hallmark regulatory networks
Clinical Cancer Research·2026
Subtype-specific sirtuin expression signatures link mitochondrial–epigenetic networks to breast cancer survival
GeroScience·2026Open Access
Prognostic impact of small leucine-rich proteoglycans in serous ovarian cancer and response to platinum-based chemotherapy
International Journal of Gynecological Cancer·2026
Self-assembly of hybrid 3D cultures by integrating living and synthetic cells
Nature Communications·2025Open Access
Supplementary Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
2025Open Access
Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
2025Open Access
Impact pathway and gene ontology analyses of <i>FOXC2</i> ‐correlated genes in melanoma reveal a role for the FOXC2 transcription factor in several oncogenic pathways and processes
Clinical and Translational Discovery·2025Open Access
Targeting the HMGB1-IL32 pathway to alleviate T cell exhaustion in epithelial ovarian cancer
GeroScience·2025Open Access
Understanding the Chemical Characteristics of Payloads and the Expression of Tumor-Associated Antigens of ADCs in Clinical Development
ACS Omega·2025Open Access
Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma
Cancer Immunology Immunotherapy·2025Open Access
Comparative Evaluation of Mutect2, Strelka2, and FreeBayes for Somatic SNV Detection in Synthetic and Clinical Whole-Exome Sequencing Data
Biomolecules·2025Open Access
Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostat
npj Precision Oncology·2025· 1 citedOpen Access
Abstract C026: Epigenetic silencing of MTAP defines a distinct class of PRMT5-inhibitor-sensitive cancers
Molecular Cancer Therapeutics·2025
The Role of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 in Breast Cancer Pathophysiology
Cells·2025Open Access
Mortality, functional outcome, and bleeding risk after early versus delayed thrombectomy
GeroScience·2025Open Access
Recent advances in treating age-related macular degeneration and diabetic retinopathy: Current therapies and emerging novel approaches
GeroScience·2025Open Access
Pathway‐level mutational signatures predict breast cancer outcomes and reveal therapeutic targets
British Journal of Pharmacology·2025· 17 cited
Senescence-associated gene signatures predict survival in lung cancer: a multi-cohort analysis
GeroScience·2025· 1 citedOpen Access
Subtype-specific genetic drivers of immune evasion in breast cancer
Immuno-Oncology Technology·2025Open Access
page 1 of 65Next →

Frequent Co-authors

András Lánczky(9), Ádám Nagy(7), Jan Budczies(6), Otília Menyhárt(5), Carsten Denkert(4), Gyöngyi Munkácsy(4), Zoltán Szállási(3), Libero Santarpia(3), G. M. Stocks(3), Lajos Pusztai(3), Eric R. Fearon(3), Yatrik M. Shah(3), Aron C. Eklund(2), Qiyuan Li(2), Paweł Surowiak(2), Frederick Klauschen(2), András Szabó(2), Giulia Bottai(2), János Tibor Fekete(2), Giampaolo Bianchini(2)